Home  »  Finance   »  Recursion Pharmaceuticals Inc.: Navigating Market ...

Recursion Pharmaceuticals Inc.: Navigating Market Fluctuations with a 1.82B Market Cap

The present stock price for Recursion Pharmaceuticals Inc. (RXRX) is $8.57. In the last trading session, the stock made a considerable jump, reaching $8.72 after an opening price of $8.66. The stock briefly fell to $8.36 before ending the session at $8.60.

The market performance of Recursion Pharmaceuticals Inc.’s stock has been turbulent in recent times. Over the last year, the company’s stock reached its highest point at $16.75 on 07/19/23, while the lowest value for the same duration was $4.54 on 05/02/23.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


52-week price history of RXRX Stock

A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Recursion Pharmaceuticals Inc.’s current trading price is -48.82% away from its 52-week high, while its distance from the 52-week low is 88.77%. The stock’s price range during this period has spanned from $4.54 to $16.75. In the Healthcare sector, the Recursion Pharmaceuticals Inc.’s shares surpassed a trading volume of approximately 17.54 million for the day, which was noticeably higher compared to the average daily volume of 9.6.28 million over the past three months.

Market Capitalization and Financial Performance: An In-Depth Look

Recursion Pharmaceuticals Inc. (RXRX) has experienced a quarterly decline of -7.85% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.82B and boasts a workforce of 500 employees.

Making Sense of Trading Volume and Moving Average Data

Based on Barchart.com data, the company’s moving average over the 100-day period was 8.90, with a change in price of +3.17. Similarly, Recursion Pharmaceuticals Inc. recorded 5,058,717 in trading volume during the last 100 days, posting a change of +58.70%.

Examining RXRX’s Debt-to-Equity Ratio: What You Need to Know

The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for RXRX stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.

RXRX Stock Stochastic Average

Today, Recursion Pharmaceuticals Inc.’s raw stochastic average for the past 50 days stands at 19.50%, indicating a decline from the raw stochastic average of the last 20 days, which was 32.65%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 33.67% and 31.92% respectively.

RXRX Stock Price Performance Analysis

The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The index has shown a price gain of 11.15% this year. Over the last six months, there has been a weaker performance of 12.03%. The price of RXRX leaped by -1.49% during the last 30 days period. For the last 5-days stocks have improved 6.33%.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts